CITATION: Araj GF. 1999. Antimicrobial resistance in Lebanon. APUA Newsletter 17(1): 1, 4.


Newsletter table of contents

 

Print this Page

Email this Page


Antimicrobial resistance in Lebanon
George F Araj, PhD
American University of Beirut Medical Center, Beirut, Lebanon


The increase in resistance to antimicrobial agents among microorganisms has been recognized worldwide and Lebanon is no exception. Since the cessation of civil war in the early 1990s, several studies conducted at the American University of Beirut Medical Center have demonstrated the antimicrobial susceptibility patterns of bacteria (1-6), mycobacteria (7) and
Candida (8) clinical isolates.

Moreover, an antibiogram annual report is generated for the associated 450-bed teaching hospital which provides acute and tertiary care to patients of all ages in Lebanon. Each year, the hospital has approximately 16,000 admissions, 90,000 outpatient visits and 30,000 cases treated at the emergency unit. High frequency of antimicrobial resistance is found among bacteria isolated at the American University of Beirut Medical Center (Table 1).

Observed Antibiotic Resistance
Among the Gram-positive cocci, the frequency of methicillin-resistant
Staphylococcus aureus (MRSA) rose from 3% in 1971 to 38% in 1998. Approximately one-third of the penicillin-resistant Streptococcus pneumoniae had a penicillin MIC >1 ug/ml. Resistance to macrolides also appears to be on the rise: Between 1992 and 1998, erythromycin resistance among S. pyogenes and S. viridans isolates rose from zero to 8% and 4% to 20%, respectively. These, however, remain uniformly susceptible to penicillin. Thus far, no vancomycin-resistant enterococci have been detected. Currently, enterococcus isolates are being collected to determine vancomycin and aminoglycoside resistance based on established criteria.

Among Gram-negative bacteria in 1998, the prevalence of strains with extended spectrum beta-lactamases (ESBLs) among
Escherichia coli and Klebsiella pneumoniae isolates were 3.3% and 6.4%, respectively. Significant rates of multidrug-resistant nonfermenters have been observed mainly among Acinetobacter spp. and Pseudomonas spp. Resistance to all commonly used antimicrobial agents was detected among four isolates of P. aeruginosa. Strains of Acinetobacter spp. susceptible only to imipenem were frequently encountered.

No antimicrobial resistance was detected among
Salmonella typhi; contrarily, non-typhi Salmonella spp. exhibited resistance to ampicillin ranging from 17% to 30% and to trimethoprim-sulphamethoxazole ranging from 6% to 15%.

Among
Campylobacter spp., high resistance rates were encountered against several antimicrobial agents: ampicillin (31%), erythromycin (53%), cipro-floxacin (61%), tetracycline (51%) and chloramphenicol (23%).

Drug resistance among
M. tuberculosis was also high for isolates recovered from both newly diagnosed cases and previously treated cases with higher resistancce rates being observed in the latter group (Table 2). Overall, 14.6% of the isolates were resistant to two or more drugs.

Resistance rates of 0% to 6% were found in
C. albicans against the tested antifungal drugs and in C. tropicalis only against itraconazole (17%) (Table 3).

Bacterial, mycobacterial and
Candida isolates from Lebanon generally show high rates of antimicrobial resistance. Comparing these rates with those from other regions in the world, Lebanon seems to fall between figures reported from the Persian Gulf countries which are higher and those from medical centers in the United States and Europe which are lower. Continuous education, surveillance and control programs are warranted to combat these high antimicrobial resistance rates in both Lebanon and worldwide (9).

References

  1. Araj GF, Alami SY, Uwaydah MM. 1994. Diag Microbiol Infect Dis 20:151-158.
  2. Saksouk S, Araj GF. l995. Abstract presented 95th Annual Meeting of the American Society for Microbiology, Washington, DC, May 2l-25: A-82, p. 157.
  3. Abdo RA, Araj GF, Talhouk RS. 1996. Leb Med J 44:21-30.
  4. Uwaydah M, Jradeh M, Shihab Z. 1996. J Antimicrob Chemother 38:283-286.
  5. Araj GF. 1997. Ann Saudi Med 17(4):488.
  6. Talhouk RS, El-Dana RA, Barbour E, Araj GF. 1997. Abstract presented at the 97th Annual Meeting of the American Society for Microbiology, Miami Beach, FL, May 4-8:C-273, p. l68.
  7. Hamzeh MM, Araj GF. 1997. Int J Tuberc Lung Dis 1(4):314-318.
  8. Araj GF, Daher NK, Tabbarah ZA. 1998. Int J Antimicrob Agents (in press).
  9. Araj GF, Nassar NT, Bey HA, Alami SY. 1997. BMJ (Middle East) 4(39):17-23.
 

ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS © 1999

| Home | About APUA | Int'l Chapters | Contact Us | Search |
|
Consumer Information | Practitioner Information | Research & Surveillance | News |